Nuzenio

Retinal Disease

Retinal Disease news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 15 publisher sources 100/100 entity strength

Latest news

EyeWorld Weekly, August 7, 2026 - EyeWorldEyeWorld · Fri, 07 Aug 2026 16:04:01 GMT Eyedaptic Announces Positive Clinical Results Presented at American Retina Forum National Meeting - EIN PresswireEIN Presswire · Fri, 07 Aug 2026 13:00:00 GMT Tarsus to acquire Alkeus Pharma, adding retina repertoire - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 11:54:03 GMT First human trial of gene-silencing therapy launched to treat vision-threatening effects of Bardet-Biedl syndrome - Ophthalmology Times EuropeOphthalmology Times Europe · Fri, 07 Aug 2026 11:06:32 GMT U.S. AI-enabled Ophthalmic Diagnostic Devices Market (2026 - 2033) - Grand View ResearchGrand View Research · Fri, 07 Aug 2026 07:12:02 GMT Faricimab in the Treatment of Retinal Disease: A Narrative Review - CureusCureus · Fri, 07 Aug 2026 06:26:24 GMT Tarsus to purchase Alkeus Pharmaceuticals - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Thu, 06 Aug 2026 19:19:22 GMT Adding to its retina repertoire, Tarsus buys Alkeus in $800M deal - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 18:11:57 GMT

Timeline

Fri, 07 Aug 2026 16:04:01 GMTEyeWorld Weekly, August 7, 2026 - EyeWorld

Fri, 07 Aug 2026 13:00:00 GMTEyedaptic Announces Positive Clinical Results Presented at American Retina Forum National Meeting - EIN Presswire

Fri, 07 Aug 2026 11:54:03 GMTTarsus to acquire Alkeus Pharma, adding retina repertoire - The Pharma Letter

Fri, 07 Aug 2026 11:06:32 GMTFirst human trial of gene-silencing therapy launched to treat vision-threatening effects of Bardet-Biedl syndrome - Ophthalmology Times Europe

Fri, 07 Aug 2026 07:12:02 GMTU.S. AI-enabled Ophthalmic Diagnostic Devices Market (2026 - 2033) - Grand View Research

Fri, 07 Aug 2026 06:26:24 GMTFaricimab in the Treatment of Retinal Disease: A Narrative Review - Cureus

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Tarsus9 live mentions Ophthalmology Times Europe6 live mentions Alkeus6 live mentions Phase4 live mentions The Pharma Letter3 live mentions Grand View Research3 live mentions Eyes On Eyecare3 live mentions Eyewire3 live mentions Drug Target Review3 live mentions August2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Retinal Disease.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.